MedPath

迪康倍(苏州)生物医药科技有限公司

Ownership
-
Established
2020-05-14
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Everolimus Tablets

Product Name
依维莫司片
Approval Number
国药准字H20253001
Approval Date
Jan 2, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.